Malta - engelsk - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - amoxicillin, clavulanic acid - film-coated tablet - amoxicillin 250 mg clavulanic acid 125 mg - antibacterials for systemic use

Malta - engelsk - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - amoxicillin, clavulanic acid - film-coated tablet - amoxicillin 875 mg clavulanic acid 125 mg - antibacterials for systemic use

Irland - engelsk - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - amoxicillin; clavulanic acid - film-coated tablet - 500 mg/ 125 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor - : antibacterials for systemic use, combinations of penicillins, incl. beta-lactamase inhibitors - - acute bacterial sinusitis (adequately diagnosed) - acute otitis media - acute exacerbations of chronic bronchitis (adequately diagnosed) - community acquired pneumonia - cystitis - pyelonephritis - skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis. - bone and joint infections, in particular osteomyelitis.

Filippinene - engelsk - FDA (Food And Drug Administration)

actimed distributions inc - amoxicillin (as trihydrate) , clavulanic acid - powder for oral suspension - 200mg/28.5mg/5ml

Irland - engelsk - HPRA (Health Products Regulatory Authority)

v.m.d. n.v/s.a. - amoxicillin trihydrate; potassium clavulanate - tablet - 200, 50 mg/tablet - amoxicillin and enzyme inhibitor - dogs - antibiotics

Irland - engelsk - HPRA (Health Products Regulatory Authority)

ceva santé animale - amoxicillin; clavulanic acid - chewable tablet - 62.5 mg/tablet - amoxicillin and enzyme inhibitor - cats, dogs - antibacterial

USA - engelsk - NLM (National Library of Medicine)

rebel distributors corp - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - amoxicillin anhydrous 400 mg in 5 ml - amoxicillin and clavulanate potassium is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: lower respiratory tract infections − caused by β-lactamase−producing strains of h. influenzae and m. catarrhalis . otitis media − caused by β-lactamase−producing strains of h. influenzae and m. catarrhalis . sinusitis − caused by β-lactamase−producing strains of h. influenzae and m. catarrhalis . skin and skin structure infections − caused by β-lactamase−producing strains of s. aureus , e. coli , and klebsiella spp. urinary tract infections − caused by β-lactamase−producing strains of e. coli , klebsiella spp. and enterobacter spp. while amoxicillin and clavulanate potassium is indicated only for the conditions listed above, infections caused by ampicillin-susceptible organisms are also amenable to treatment with amoxicillin and clavulanate potassium due to its amoxicillin content. therefore, mixed infections caused by ampicilli

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

medreich plc - amoxicillin trihydrate - oral capsule - 250mg

Irland - engelsk - HPRA (Health Products Regulatory Authority)

dechra regulatory b.v. - amoxicillin trihydrate; potassium clavulanate - tablet - 200, 50 mg/tablet - amoxicillin and enzyme inhibitor

Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - amoxicillin trihydrate 573,4 mg - eq. amoxicillin 500 mg; clavulanic acid 125 mg - film-coated tablet - 500 mg - 125 mg - amoxicillin trihydrate 573.4 mg; clavulanic acid 125 mg - amoxicillin and enzyme inhibitor